Athanor Capital’s NEOPHOTONICS CORP NPTN Stock Holding History

Athanor Capital’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-15,088	Closed	-$180K	–	954
2021 Q1	$180K	Buy	+15,088	New	+$171K	﹤0.01%	751

Other funds holding NPTN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Athanor Capital's NPTN Position: Q2 2021 in Review

Athanor Capital sold out of NEOPHOTONICS CORP (NPTN) in Q2 2021, closing a stake of 15,088 shares — an estimated $180K sold.

Athanor Capital first reported a position in NPTN in Q1 2021 and held it in 1 quarter. The position peaked at $180K in Q1 2021. 138 funds tracked by Wall St. Rank hold NPTN as of Q2 2021.

Athanor Capital reported no remaining NEOPHOTONICS CORP position as of Q2 2021 after selling out during the quarter.
Athanor Capital sold 15,088 NEOPHOTONICS CORP shares in Q2 2021, an estimated $180K.
Athanor Capital first reported a position in NEOPHOTONICS CORP in Q1 2021 and held it in 1 quarter.
Athanor Capital's NEOPHOTONICS CORP position peaked at $180K in Q1 2021.
138 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2021.

Based on Athanor Capital's 13F filing for Q2 2021, filed 16 Aug 2021.